AmnioChor is a biotech company based in perinatal stem cell technology. The Company has identified a source and method of acquiring and preserving human stem cells. AmnioChor's stem cells will allow a tremendous expansion of the private stem cell storage industry and stem cell based therapies to augment the cord blood banking industry.
| Website | http://www.amniochor.com |
| Revenue | $597000 |
| Employees | View employees |
| Founded | 2008 |
| Address | 222 Merchandise Mart Plz Ste 1230, Chicago, Illinois 60654, US |
| Phone | +1 312-351-0520 |
| Industry | Business Services General, Biotechnology, Business Services, Drug Discovery |
| Competitors | Organogenesis, Acelity, Integra LifeSciences, Medytox, Sientra, Inc., LIFECELL LIMITED, Smith+Nephew, Tissue Regenix Group, AlloSource®, MyEllevate® +26 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies |
Looking for a particular AmnioChor Inc. employee's phone or email?
AmnioChor Inc. Questions
The AmnioChor Inc. annual revenue was $597000 in 2026.
AmnioChor Inc. is based in Chicago, Illinois.
The NAICS codes for AmnioChor Inc. are [54, 54171, 5417, 541713, 541].
The SIC codes for AmnioChor Inc. are [87, 873].
